ReviewCancers2026
Multiparametric Radiomics for Characterization and Outcome Prediction in Colorectal Cancer: The Central Role of Diagnostic Imaging.
Review in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND/
objectivesColorectal carcinoma (CRC) remains a leading cause of cancer-related morbidity and mortality worldwide, with increasing incidence in younger populations. Despite advances in imaging, conventional approaches remain limited by subjective interpretation and insufficient characterization of tumor heterogeneity. Radiomics, particularly in a multiparametric framework integrating computed tomography (CT), magnetic resonance imaging (MRI), and positron emission tomography (PET), has emerged as a promising tool to enhance diagnostic and prognostic performance. This review aims to critically evaluate methodological strategies for optimizing multiparametric radiomics in CRC.
methodsA narrative review was conducted based on a literature search of PubMed/MEDLINE, Scopus, and Web of Science up to March 2026. Studies focusing on CT-, MRI-, and PET-based radiomics in CRC were included. Key methodological aspects analyzed included imaging acquisition and standardization, tumor segmentation techniques, radiomic feature extraction, feature selection methods (e.g., LASSO and PCA), and model validation approaches.
resultsMultiparametric radiomics models integrating CT, MRI, and PET consistently demonstrated superior diagnostic accuracy compared to single-modality approaches, particularly in T-staging and lymph node involvement prediction. PET-derived metabolic features further enhanced characterization of tumor biology and improved prognostic stratification, including prediction of progression-free survival (PFS) and overall survival (OS). However, methodological heterogeneity, small sample sizes, and variability in imaging protocols and segmentation practices remain significant limitations affecting reproducibility and generalizability.
conclusionsMultiparametric radiomics represents a powerful advancement in precision oncology for CRC, enabling improved tumor characterization, risk stratification, and personalized treatment planning. Standardization, multicentric validation, and integration with artificial intelligence are essential for successful clinical translation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.